Chronotherapy with low-dose modified-release prednisone for the management of rheumatoid arthritis: a review

To date, rheumatoid arthritis (RA) remains a debilitating, life-threatening disease. One major concern is morning symptoms (MS), as they considerably impair the patients’ quality of life and ability to work. MS change in a circadian fashion, resembling the fluctuations of inflammatory cytokines such...

Descripción completa

Detalles Bibliográficos
Autores principales: Beltrametti, Stefano Paolo, Ianniello, Aurora, Ricci, Clara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5123661/
https://www.ncbi.nlm.nih.gov/pubmed/27920546
http://dx.doi.org/10.2147/TCRM.S112685

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5123661/
https://www.ncbi.nlm.nih.gov/pubmed/27920546
http://dx.doi.org/10.2147/TCRM.S112685

Ejemplares similares